WHITE WIDOW x 5%

Cryo Infusion in cannabis is a technique that uses ultra-low temperatures (-30°C to -80°C) to enhance the potency and flavor of cannabis flowers. It involves freezing the flowers and then infusing them with concentrated cannabinoids and terpenes.

This method preserves the natural compounds, ensures a consistent distribution of infused compounds, and results in a more potent, flavorful, and pure cannabis product. It is favored by cannabis enthusiasts seeking a premium and enhanced experience.

Gas Infusion
While gas infusion is effective, it may not preserve delicate terpenes as effectively as cryo infusion. Additionally, some gas infusion methods may require the use of solvents, which can introduce impurities and affect the overall quality of the final product. This solvent use can raise concerns about purity and potential health effects.

Spraying
Spraying, although a simple method, can be less consistent in terms of the distribution of cannabinoids and terpenes throughout the cannabis flowers. This inconsistency can result in variations in potency and flavor, making it challenging to achieve uniform quality and damaging the flower. Furthermore, spraying often involves the use of additives and carriers, which can introduce additional substances into the product, potentially impacting its purity and overall naturalness.

T9HC is a semi-synthetic cannabinoid produced through chemical conversion of hemp-derived CBD. It exhibits potent psychoactive properties and is currently unregulated in most European jurisdictions.

THC (delta-9-tetrahydrocannabinol) is a naturally occurring phytocannabinoid found in cannabis. T9HC is a synthetic derivative produced from hemp-derived CBD through laboratory processes. Both compounds exhibit psychoactive effects, though T9HC is reported to produce more intense, prolonged experiences and remains unscheduled in most European jurisdictions.

Yes. T9HC is a psychoactive compound that produces euphoric and relaxing effects upon consumption. Users report experiences lasting 6–10 hours. Dosage caution is advised for inexperienced individuals.

T9HC is synthesized through chemical conversion of cannabidiol (CBD) extracted from industrial hemp. The precise methodology is proprietary and varies by manufacturer. Production occurs exclusively in laboratory environments.

T9HC is currently legal in most European Union member states, as it is not classified under controlled THC substances. Regulatory status varies by jurisdiction and is subject to change. Consumers are advised to verify local legislation prior to purchase.

No peer-reviewed studies have evaluated T9HC's safety profile to date. Anecdotal evidence suggests tolerance among users without significant adverse effects. Recommended precautions include sourcing from verified suppliers with third-party laboratory testing and initiating use at low doses.